Literature DB >> 16957637

Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest.

Adriana Miclescu1, Samar Basu, Lars Wiklund.   

Abstract

OBJECTIVE: Methylene blue (MB), a free-radical scavenger inhibiting the production and actions of nitric oxide, may counteract excessive vasodilatation induced by nitric oxide during cardiac arrest. Effects of MB in cardiac arrest and cardiopulmonary resuscitation were investigated.
DESIGN: Randomized, prospective, laboratory animal study.
SETTING: University animal research laboratory.
SUBJECTS: A total of 63 piglets of both sexes.
INTERVENTIONS: A pig model of extended cardiac arrest (12 mins of untreated cardiac arrest and 8 mins of cardiopulmonary resuscitation) was employed to assess the addition or no addition of MB to a hypertonic saline-dextran solution. These two groups (MB and hypertonic saline-dextran group [MB group] and hypertonic saline-dextran-only group) of 21 animals were each compared with a group receiving isotonic saline (n = 21).
MEASUREMENTS AND MAIN RESULTS: Although the groups were similar in baseline values, 4-hr survival in the MB group was increased (p = .02) in comparison with the isotonic saline group. Hemodynamic variables were somewhat improved at 15 mins after restoration of spontaneous circulation in the MB group compared with the other two groups. The jugular bulb levels of 8-isoprostane-prostaglandin F2alpha and 15-keto-dihydro-prostaglandin F2alpha (indicators of peroxidation and inflammation) were significantly decreased in the MB group compared with the isotonic saline group. Significant differences were recorded between the three groups in levels of protein S-100beta (indicator of neurologic injury), with lower levels in the MB group compared with the isotonic saline and hypertonic saline-dextran-only groups. Troponin I and myocardial muscle creatine kinase isoenzyme arterial concentrations (indicators of myocardial damage) were also significantly lower in the MB group.
CONCLUSIONS: MB co-administered with a hypertonic-hyperoncotic solution increased 4-hr survival vs. saline in an experimental porcine model of cardiac arrest and reduced oxidative, inflammatory, myocardial, and neurologic injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957637     DOI: 10.1097/01.CCM.0000242517.23324.27

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Neuroprotective and Functional Improvement Effects of Methylene Blue in Global Cerebral Ischemia.

Authors:  Qing Lu; Donovan Tucker; Yan Dong; Ningjun Zhao; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

3.  H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores.

Authors:  Takashi Sonobe; Philippe Haouzi
Journal:  Clin Toxicol (Phila)       Date:  2015-05-12       Impact factor: 4.467

4.  Methylene blue counteracts H2S toxicity-induced cardiac depression by restoring L-type Ca channel activity.

Authors:  Annick Judenherc-Haouzi; Xue-Qian Zhang; Takashi Sonobe; Jianliang Song; Matthew D Rannals; JuFang Wang; Nicole Tubbs; Joseph Y Cheung; Philippe Haouzi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-09       Impact factor: 3.619

5.  Beneficial network effects of methylene blue in an amnestic model.

Authors:  Penny D Riha; Julio C Rojas; F Gonzalez-Lima
Journal:  Neuroimage       Date:  2010-11-16       Impact factor: 6.556

6.  Striatal neuroprotection with methylene blue.

Authors:  J C Rojas; N Simola; B A Kermath; J R Kane; T Schallert; F Gonzalez-Lima
Journal:  Neuroscience       Date:  2009-07-24       Impact factor: 3.590

7.  Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.

Authors:  Julio C Rojas; Joseph M John; Jung Lee; F Gonzalez-Lima
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

8.  Methylene blue potentiates stimulus-evoked fMRI responses and cerebral oxygen consumption during normoxia and hypoxia.

Authors:  Shiliang Huang; Fang Du; Yen-Yu I Shih; Qiang Shen; F Gonzalez-Lima; Timothy Q Duong
Journal:  Neuroimage       Date:  2013-01-26       Impact factor: 6.556

9.  Antidotal effects of methylene blue against cyanide neurological toxicity: in vivo and in vitro studies.

Authors:  Philippe Haouzi; Marissa McCann; JuFang Wang; Xue-Qian Zhang; Jianliang Song; Ilker Sariyer; Diane Langford; Maryline Santerre; Nicole Tubbs; Annick Haouzi-Judenherc; Joseph Y Cheung
Journal:  Ann N Y Acad Sci       Date:  2020-05-06       Impact factor: 5.691

10.  Effectiveness of Methylene Blue in the Prevention of Stifle Joint Arthrofibrosis in Rabbit Models.

Authors:  Hamid Namazi; Mohammad J Emami; Fatemeh Dehghani Nazhvani; Ali Dehghani Nazhvani; Zeinab Kargarshouroki
Journal:  Arch Bone Jt Surg       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.